| mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
| mRNA |
Erlotinib |
FIMM |
pan-cancer |
AAC |
0.61 |
4e-05 |
| mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |
| mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |
| mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
0.17 |
7e-05 |
| mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |
| mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |